From: Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS
 | Alive (n = 69) | Dead (n = 25) | p |
---|---|---|---|
Age (year) | 62 ± 13 | 68 ± 12 | 0.033 |
Sex M (%) | 53 (77) | 17 (68) | 0.549 |
Disease duration (day) | 7.7 ± 3.3 | 7.7 ± 3.1 | 0.942 |
Lung disease (%) | 17 (25) | 11 (44) | 0.079 |
Coronary artery disease (%) | 14 (20) | 3 (12) | 0.545 |
Cardiovascular comorbidities | |||
 Hypertension (%) | 44 (64) | 19 (76) | 0.362 |
 Diabetes (%) | 11 (16) | 5 (20) | 0.99 |
 Smoke (%) | 7 (10) | 8 (32) | 0.021 |
 Obesity (%) | 18 (26) | 13 (52) | 0.025 |
Treatment | |||
 Anticoagulants (%) | 69 (100) | 24 (96) | 0.097 |
 Hydroxycloroquine (%) | 51 (74) | 19 (76) | 0.840 |
 Antivirals (%) | 43 (62) | 23 (92) | 0.005 |
 Monoclonal antibodies (%) | 8 (12) | 10 (40) | 0.005 |
 Corticosteroids (%) | 14 (20) | 6 (24) | 0.98 |
Type of ventilation | |||
 Nasal oxygen (%) | 35 (51) | 0 (0) |  < 0.001 |
 Noninvasive ventilation (%) | 22 (32) | 0 (0) |  < 0.001 |
 Intubation (%) | 12 (17) | 25 (100) |  < 0.032 |
Biochemistry | |||
 Creatinine (mg/dl) | 1.3 ± 1.3 | 2.8 ± 1.4 |  < 0.001 |
 Cardiac Troponin I (pg/l) | 365 ± 644 | 1245 ± 2049 |  < 0.002 |
 D-dimer (ng/ml) | 317 ± 557 | 919 ± 974 |  < 0.001 |
 C-reactive protein (mg/dl) | 10.6 ± 19.9 | 22.8 ± 27.3 |  < 0.023 |
 Procalcitonin (ng/ml) | 0.6 ± 1.5 | 1.8 ± 2.0 |  < 0.005 |
 APTT (sec) | 36.8 ± 6.7 | 40.6 ± 4.3 | 0.037 |
 NT-proBNP (pg/ml) | 686 ± 1224 | 3375 ± 3891 |  < 0.001 |
 Interleukine-6 (ng/ml) | 33.6 ± 33.4 | 246.4 ± 87.4 |  < 0.001 |
 PaO2/FiO2 ratio (mmHg) | 270 ± 104 | 117 ± 56 |  < 0.001 |